Zimmer Biomet Holdings Raises FY2025 Adj EPS Guidance from $7.90-$8.10 to $8.10-$8.30 vs $7.97 Est; Narrows FY2025 Sales Guidance from $8.117B-$8.309B to $8.190B-$8.270B vs $8.184B Est

2025-08-07 18:33

WisdomTree美国大型股ETF(EPS) 0

Financial Guidance

The Company is updating its full-year 2025 financial guidance to tighten full-year 2025 reported, constant currency and organic constant currency1 revenue guidance and increase adjusted2 earnings per share financial guidance:

Projected Year Ending December 31, 2025
	Previous Guidance	Updated Guidance
2025 Reported Revenue Change	5.7% - 8.2%	6.7%- 7.7%
Foreign Currency Exchange Impact	0.0% - 0.5%	0.5 %
2025 Constant Currency Revenue Change	5.7% - 7.7%	6.2% - 7.2%
2025 Organic Constant Currency Revenue Change(1)	3.0% - 5.0%	3.5% - 4.5%
Adjusted Diluted EPS(2)	$7.90 - $8.10	$8.10 - $8.30

Zimmer Biomet Holdings Raises FY2025 Adj EPS Guidance from $7.90-$8.10 to $8.10-$8.30 vs $7.97 Est; Narrows FY2025 Sales Guidance from $8.117B-$8.309B to $8.190B-$8.270B vs $8.184B Est

推荐文章

港股周报 | 中国大模型“春节档”打响！智谱周涨超138%；巨亏超230亿！美团周内重挫超10%

一周财经日历 | 港美股迎“春节+总统日”双假期！万亿零售巨头沃尔玛将发财报

一周IPO | 赚钱效应持续火热！年内24只上市新股“0”破发；“图模融合第一股”海致科技首日飙涨逾242%

从软件到房地产，美国多板块陷入AI恐慌抛售潮

Meta计划为智能眼镜添加人脸识别技术

危机四伏，市场却似乎毫不在意

美股机会日报 | 降息预期升温！美国1月CPI年率创去年5月来新低；净利、指引双超预期！应用材料盘前涨超10%

财报前瞻 | 英伟达Q4财报放榜在即！高盛、瑞银预计将大超预期，两大关键催化将带来意外惊喜？